Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer.

T Susanna MeijerJan H N DietersEleonora M de LeedeLioe-Fee De Geus-OeiJaap VuijkChristian H MartiniArian R van ErkelJacob LutjeboerRutger W van der MeerFred G J TijlEllen KapiteijnAlexander L VahrmeijerMark C Burgmans

Published in: PloS one (2022)

M-PHP is a safe procedure with only limited efficacy in patients with unresectable CRLM who already showed progression of disease after receiving one or more systemic treatment regimens.

Keyphrases

liver metastases
minimally invasive
high dose
locally advanced
computed tomography
combination therapy
magnetic resonance
ultrasound guided
replacement therapy
contrast enhanced